Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
303.44
+6.54 (2.20%)
May 27, 2026, 11:37 AM EDT - Market open
Bio-Rad Laboratories Revenue
Bio-Rad Laboratories had revenue of $592.10M in the quarter ending March 31, 2026, with 1.14% growth. This brings the company's revenue in the last twelve months to $2.59B, up 1.92% year-over-year. In the year 2025, Bio-Rad Laboratories had annual revenue of $2.58B with 0.65% growth.
Revenue (ttm)
$2.59B
Revenue Growth
+1.92%
P/S Ratio
3.07
Revenue / Employee
$347,638
Employees
7,450
Market Cap
8.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.58B | 16.70M | 0.65% |
| Dec 31, 2024 | 2.57B | -104.70M | -3.92% |
| Dec 31, 2023 | 2.67B | -131.00M | -4.67% |
| Dec 31, 2022 | 2.80B | -120.35M | -4.12% |
| Dec 31, 2021 | 2.92B | 376.92M | 14.81% |
| Dec 31, 2020 | 2.55B | 233.97M | 10.12% |
| Dec 31, 2019 | 2.31B | 22.24M | 0.97% |
| Dec 31, 2018 | 2.29B | 129.27M | 5.98% |
| Dec 31, 2017 | 2.16B | 91.98M | 4.45% |
| Dec 31, 2016 | 2.07B | 48.73M | 2.41% |
| Dec 31, 2015 | 2.02B | -155.60M | -7.15% |
| Dec 31, 2014 | 2.18B | 42.35M | 1.99% |
| Dec 31, 2013 | 2.13B | 63.45M | 3.07% |
| Dec 31, 2012 | 2.07B | -4.29M | -0.21% |
| Dec 31, 2011 | 2.07B | 146.41M | 7.60% |
| Dec 31, 2010 | 1.93B | 142.88M | 8.01% |
| Dec 31, 2009 | 1.78B | 19.87M | 1.13% |
| Dec 31, 2008 | 1.76B | 303.32M | 20.76% |
| Dec 31, 2007 | 1.46B | 187.12M | 14.69% |
| Dec 31, 2006 | 1.27B | 92.94M | 7.87% |
| Dec 31, 2005 | 1.18B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zimmer Biomet Holdings | 8.41B |
| Smith & Nephew | 6.16B |
| Bruker | 3.46B |
| Globus Medical | 3.10B |
| Insulet | 2.90B |
| Bio-Rad Laboratories | 2.59B |
| Masimo | 1.56B |
| Penumbra | 1.45B |
BIO News
- 2 days ago - Bio-Rad price target raised to $310 from $290 at Wells Fargo - TheFly
- 8 days ago - Bio-Rad Laboratories Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Bio-Rad rises 11.6% - TheFly
- 9 days ago - Bio-Rad rises 10.5% - TheFly
- 9 days ago - Activist Elliott Takes Major Stake in Bio-Rad — Can It Boost BIO Stock Price? - TipRanks
- 9 days ago - Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports - Reuters
- 9 days ago - Activist investor Elliot builds big stake in Bio-Rad, WSJ says - TheFly
- 9 days ago - Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad - WSJ